GO:2001251 negative regulation of chromosome organization: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:2001251 describes any process that stops, prevents, or reduces the frequency, rate, or extent of chromosome organization.
• It is a biological_process term that includes negative regulation of chromosome organisation, chromosome organization and biogenesis, maintenance of genome integrity, and nuclear genome maintenance.
• Key molecular players include chromatin remodelers (INO80, BAF), histone deacetylases (HDACs), and structural proteins such as CTCF [1,4,5,6].
• Dysregulation of this process is linked to cancer, developmental disorders, and genome instability [1,5,6].
• CRISPR-based knockout, point mutation, knock-in, and overexpression models are essential to dissect the causal roles of genes in this process [2,3,7].
• Studying GO:2001251 requires integrating chromatin assays, imaging, and functional genomics to understand how chromosome organization is restrained [4,7,8].
Description
Chromosome organization is a fundamental process that ensures proper DNA packaging, replication, and segregation. Negative regulation of chromosome organization (GO:2001251) refers to any process that stops, prevents, or reduces the frequency, rate, or extent of chromosome organization. This regulatory mechanism is critical for maintaining genome integrity and preventing aberrant chromosomal structures that can lead to disease. Researchers study this term to understand how cells balance chromosome dynamics and stability, and how disruptions contribute to pathologies such as cancer and developmental disorders [1,5,6]. The importance of negative regulation is underscored by the diverse molecular players involved, including chromatin remodeling complexes, histone-modifying enzymes, and architectural proteins like CTCF [4,5,6]. Understanding these processes provides insights into basic cell biology and offers potential therapeutic targets for diseases characterized by genome instability [1,7].
negative regulation of chromosome organization At A Glance
| GO ID | GO:2001251 |
|---|---|
| GO term | negative regulation of chromosome organization |
| Ontology | biological_process |
| Synonym | negative regulation of chromosome organisation; negative regulation of chromosome organization and biogenesis; negative regulation of maintenance of genome integrity; negative regulation of nuclear genome maintenance |
| Major function | Stops, prevents, or reduces the frequency, rate, or extent of chromosome organization |
| Related processes | Chromatin remodeling, histone modification, chromosome segregation, DNA repair |
| Key regulators | HDACs, INO80 complex, BAF complex, CTCF, FIGNL1-FIRRM |
| Disease relevance | Cancer, genome instability, developmental disorders |
What Is GO:2001251?
GO:2001251 is defined as any process that stops, prevents, or reduces the frequency, rate, or extent of chromosome organization. It encompasses negative regulation of chromosome organisation, chromosome organization and biogenesis, maintenance of genome integrity, and nuclear genome maintenance. This term is a biological_process and is essential for controlling when and where chromosome organization occurs, thereby safeguarding genomic stability.
Why Is negative regulation of chromosome organization Important in Cell Biology?
Negative regulation of chromosome organization is crucial for maintaining genomic integrity and preventing diseases such as cancer. It ensures that chromosome organization occurs only when needed, avoiding aberrant chromatin structures that can lead to mutations and chromosomal rearrangements [1,5,6]. This process is also vital for proper gene expression, DNA replication, and cell division, making it a central node in cellular homeostasis [4,7].
• Prevents inappropriate chromosome condensation or decondensation that could impair DNA transactions.
• Maintains genome integrity by limiting aberrant recombination and chromosome rearrangements.
• Regulates chromatin accessibility and gene expression programs [3,4].
• Influences cell cycle progression and checkpoint control.
• Modulates immune and inflammatory responses through chromatin architecture.
• Plays a role in stem cell maintenance and differentiation.
• Dysregulation is associated with cancer, including T-cell acute lymphoblastic leukemia.
• Contributes to viral strategies for nucleosome management.
• Provides targets for epigenetic therapies, such as HDAC inhibitors.
• Essential for understanding lamina-associated domain function and nuclear organization.
What Happens During negative regulation of chromosome organization?
Initiation of negative regulation
In simple terms: The cell senses when chromosome organization needs to be slowed down or stopped.
Negative regulation of chromosome organization is initiated by signals that recruit repressive complexes to specific chromosomal regions. For example, the INO80 chromatin remodeling complex can negatively regulate p21Waf1/Cip1, impacting cell cycle arrest and chromosome stability. Similarly, the BAF complex regulates oncogenic programs in T-cell acute lymphoblastic leukemia, highlighting its role in controlling chromosome organization.
Chromatin remodeling and histone modification
In simple terms: Enzymes modify histones and remodel nucleosomes to compact or loosen chromatin, thereby inhibiting organization.
Histone deacetylases (HDACs) remove acetyl groups from histones, leading to chromatin compaction and transcriptional repression, which negatively regulates chromosome organization. The canonical BAF complex also remodels nucleosomes to repress specific gene programs, affecting chromosome architecture. Additionally, O-GlcNAcylation of CTCF regulates 3D chromatin structure, demonstrating post-translational control of chromosome organization.
Structural maintenance and looping
In simple terms: Proteins like CTCF and cohesin create loops that can block or reduce chromosome organization.
CTCF is a key architectural protein that organizes chromatin loops and boundaries. Its modification by O-GlcNAcylation affects its ability to regulate 3D chromatin structure, thereby negatively regulating chromosome organization. Lamina-associated domains (LADs) involve chromatin protein complexes that repress gene expression and maintain nuclear organization, contributing to negative regulation.
Meiotic recombination control
In simple terms: During meiosis, proteins like FIGNL1-FIRRM prevent excessive recombination to protect chromosome integrity.
The FIGNL1-FIRRM complex is essential for meiotic recombination and prevents DNA damage-independent RAD51 and DMC1 loading, thereby negatively regulating chromosome organization during meiosis. This control is critical for proper chromosome segregation and genome stability.
Viral modulation of nucleosome management
In simple terms: Viruses can manipulate host nucleosome organization to favor their replication.
Baculoviruses encode proteins that manage nucleosomes, negatively regulating chromosome organization to enhance viral gene expression and replication. This highlights evolutionary conservation of negative regulation mechanisms.
Key Genes Involved in GO:2001251 negative regulation of chromosome organization
The following genes and proteins are key players in negative regulation of chromosome organization, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HDAC1 | Histone deacetylation, chromatin compaction | Cancer therapy target |
| HDAC2 | Histone deacetylation, transcriptional repression | Epigenetic modulation |
| INO80 | Chromatin remodeling, negative regulation of p21 | Cell cycle and chromosome stability |
| CTCF | Chromatin looping, insulator function | 3D chromatin structure regulation |
| BAF complex (SMARCA4) | Nucleosome remodeling, gene repression | Oncogenic programs in T-ALL |
| FIGNL1 | Meiotic recombination control | Prevents aberrant RAD51/DMC1 loading |
| FIRRM | Complex with FIGNL1 | Meiotic recombination and genome stability |
| RAD51 | Homologous recombination | Regulated by FIGNL1-FIRRM |
| DMC1 | Meiotic recombination | Regulated by FIGNL1-FIRRM |
| IL-1β | Inflammatory cytokine | Chromatin-regulated biphasic circuit |
| Lamin A/C | Nuclear lamina, LAD organization | Lamina-associated domains |
| HP1 | Heterochromatin formation | Gene repression in LADs |
| O-GlcNAc transferase (OGT) | O-GlcNAcylation of CTCF | Regulates 3D chromatin |
| SMARCB1 | BAF complex subunit | Chromatin remodeling |
| SMARCC1 | BAF complex subunit | Chromatin remodeling |
| Baculovirus proteins | Nucleosome management | Viral modulation |
How Is negative regulation of chromosome organization Regulated?
Negative regulation of chromosome organization is itself tightly regulated. For example, the INO80 chromatin remodeling complex is implicated in cell cycle phase G2/M arrest and abnormal chromosome stability, suggesting cell cycle-dependent control. The BAF complex is regulated by developmental and oncogenic signals, affecting its repressive functions. Additionally, O-GlcNAcylation of CTCF provides a dynamic post-translational mechanism to modulate chromatin architecture in response to cellular metabolic state. Inflammatory signals can also influence chromatin organization through biphasic circuits involving IL-1β.
negative regulation of chromosome organization and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HDAC1/2 | Cancer | Knockout in cancer cell lines, HDAC inhibitor treatment |
| BAF complex (SMARCA4) | T-cell acute lymphoblastic leukemia | Knockout or point mutation in T-ALL cell lines |
| FIGNL1 | Meiotic recombination defects, infertility | Knockout mouse models, spermatocyte analysis |
| CTCF | Developmental disorders, cancer | Point mutation knock-in of O-GlcNAc sites |
| Lamin A/C | Laminopathies, genome instability | Knockout or overexpression in fibroblasts |
Cancer
Dysregulation of negative regulation of chromosome organization is frequently observed in cancer. HDAC inhibitors are used in cancer therapy to modulate chromatin compaction and gene expression. The BAF complex regulates oncogenic programs in T-cell acute lymphoblastic leukemia, and its perturbation leads to aberrant chromosome organization. INO80 complex-mediated negative regulation of p21 affects cell cycle and chromosome stability, contributing to tumorigenesis.
Genome instability and developmental disorders
Defects in negative regulation can cause genome instability. The FIGNL1-FIRRM complex prevents DNA damage-independent RAD51 and DMC1 loading during meiosis; its loss leads to meiotic recombination defects and potential aneuploidy. Lamina-associated domain proteins maintain nuclear organization, and their disruption is linked to laminopathies and developmental disorders.
Inflammatory diseases
Chromatin-regulated biphasic circuits coordinate IL-1β-mediated inflammation, indicating that negative regulation of chromosome organization impacts inflammatory responses. Modulating these pathways could offer therapeutic avenues for inflammatory diseases.
Viral infections
Baculoviruses manipulate host nucleosome management to promote infection, highlighting how pathogens exploit negative regulation of chromosome organization. Understanding these mechanisms may inform antiviral strategies.
From negative regulation of chromosome organization-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X negatively regulate chromosome organization? | CRISPR knockout cell lines followed by chromosome conformation assays |
| What is the role of a specific phosphorylation site in CTCF? | Point mutation knock-in via CRISPR |
| How does a disease-associated mutation affect chromosome organization? | Knock-in of mutant allele in isogenic cell lines |
| Where does protein Y localize during negative regulation? | Tagged knock-in with fluorescent protein |
| Does overexpression of gene Z alter chromosome stability? | Doxycycline-inducible overexpression system |
| What genes are essential for negative regulation in a genome-wide screen? | CRISPR library screening |
How to Study the negative regulation of chromosome organization Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Hi-C | 3D chromatin interactions | Detect changes in chromosome organization |
| ChIP-seq | Protein-DNA binding genome-wide | Map CTCF, BAF, histone marks [4,5] |
| Live-cell imaging | Dynamic localization of proteins and loci | Track meiotic recombination proteins |
| CRISPR screen | Gene essentiality or phenotype | Identify negative regulators [1,6] |
| RNA-seq | Transcriptional changes | Assess gene expression upon perturbation |
| Proteomics | Protein interactions and modifications | Identify complexes like FIGNL1-FIRRM |
| ATAC-seq | Chromatin accessibility | Measure open chromatin regions |
| Flow cytometry | Cell cycle and chromosome stability | Evaluate G2/M arrest and aneuploidy |
Chromosome conformation capture (3C, Hi-C)
Hi-C and related techniques measure 3D chromatin interactions and can reveal changes in chromosome organization upon negative regulation. For example, O-GlcNAcylation of CTCF alters 3D chromatin structure, detectable by Hi-C.
Chromatin immunoprecipitation (ChIP-seq)
ChIP-seq identifies genome-wide binding sites of proteins involved in negative regulation, such as CTCF, BAF subunits, and histone modifications. This helps map regions where chromosome organization is repressed [4,5].
Live-cell imaging
Fluorescence microscopy of tagged proteins and chromosome loci allows real-time visualization of chromosome dynamics and the impact of negative regulators. For instance, tracking RAD51 and DMC1 loading in meiosis.
Functional genomics screens
CRISPR knockout or activation screens can identify genes that negatively regulate chromosome organization. Such screens have uncovered roles for chromatin remodelers and histone modifiers [1,6].
How CRISPR Can Be Used to Study GO:2001251 negative regulation of chromosome organization
Knockout
CRISPR knockout of genes such as HDAC1, INO80, or BAF subunits can reveal their roles in negative regulation of chromosome organization. For example, INO80 knockout leads to abnormal chromosome stability and cell cycle arrest. Knockout of FIGNL1 causes meiotic recombination defects.
Point Mutation
Point mutations can dissect specific residues required for negative regulation. For instance, mutating O-GlcNAcylation sites on CTCF affects its ability to regulate 3D chromatin structure. Such models are valuable for understanding post-translational control.
Knock-in
Knock-in of disease-associated alleles or tagged versions of proteins allows precise study of negative regulation. For example, knocking in a mutant BAF subunit can model T-ALL and assess its impact on chromosome organization. Tagged knock-in of lamin A/C enables live imaging of LADs.
Overexpression
Overexpression of negative regulators can suppress chromosome organization. For example, overexpressing HDACs enhances chromatin compaction and represses transcription. Inducible overexpression systems allow temporal control of negative regulation.
How EDITGENE Supports negative regulation of chromosome organization Research
Researchers studying negative regulation of chromosome organization-related genes often need to determine whether a candidate gene is causally involved in restraining chromosome dynamics. EDITGENE provides comprehensive CRISPR-based services to create precise cellular models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of chromosome organization research.
Frequently Asked Questions About negative regulation of chromosome organization
What is GO:2001251?
GO:2001251 is a Gene Ontology term for negative regulation of chromosome organization, defined as any process that stops, prevents, or reduces the frequency, rate, or extent of chromosome organization.
What genes are involved in negative regulation of chromosome organization?
Key genes include HDAC1, HDAC2, INO80, CTCF, BAF complex subunits (SMARCA4, SMARCB1), FIGNL1, FIRRM, and lamin A/C [1,2,4,5,6,7].
How does negative regulation of chromosome organization affect cancer?
Dysregulation can lead to aberrant chromatin structure and gene expression, contributing to cancers such as T-cell acute lymphoblastic leukemia and solid tumors [1,5,6].
What experimental methods study negative regulation of chromosome organization?
Common methods include Hi-C, ChIP-seq, live-cell imaging, CRISPR screens, RNA-seq, and proteomics [2,3,4,5,6,7].
What is the role of CTCF in chromosome organization?
CTCF is an architectural protein that organizes chromatin loops; its O-GlcNAcylation negatively regulates 3D chromatin structure.
How do HDAC inhibitors relate to this process?
HDAC inhibitors modulate histone acetylation, affecting chromatin compaction and thus negative regulation of chromosome organization, and are used in cancer therapy.
What is the FIGNL1-FIRRM complex?
It is essential for meiotic recombination and prevents DNA damage-independent RAD51 and DMC1 loading, thereby negatively regulating chromosome organization during meiosis.
Can viruses manipulate negative regulation of chromosome organization?
Yes, baculoviruses encode proteins that manage nucleosomes to promote infection, illustrating viral exploitation of this process.
What diseases are linked to defects in negative regulation of chromosome organization?
Cancer, genome instability, developmental disorders, inflammatory diseases, and viral infections [1,2,3,5,7,8].
How can CRISPR help study negative regulation of chromosome organization?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise dissection of gene function in this process [2,4,5,6,7].
Conclusion
Negative regulation of chromosome organization (GO:2001251) is a critical biological process that safeguards genome integrity by restraining chromosome dynamics. Its dysregulation is implicated in cancer, developmental disorders, and other diseases. Understanding the molecular players and mechanisms requires advanced experimental models, and CRISPR-based approaches are indispensable for causal studies. EDITGENE offers a comprehensive suite of services to support research in this field, from knockout and point mutation models to library screening and bioinformatics.
References
- 1. Ramaiah MJ et al.. 2021. Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy.. Life Sci 277:119504 PMID: 33872660
- 2. Zainu A et al.. 2024. FIGNL1-FIRRM is essential for meiotic recombination and prevents DNA damage-independent RAD51 and DMC1 loading.. Nat Commun 15(1):7015 PMID: 39147779
- 3. Fok ET et al.. 2024. A chromatin-regulated biphasic circuit coordinates IL-1β-mediated inflammation.. Nat Genet 56(1):85-99 PMID: 38092881
- 4. Tang X et al.. 2024. The PTM profiling of CTCF reveals the regulation of 3D chromatin structure by O-GlcNAcylation.. Nat Commun 15(1):2813 PMID: 38561336
- 5. Aoki K et al.. 2024. Canonical BAF complex regulates the oncogenic program in human T-cell acute lymphoblastic leukemia.. Blood 143(7):604-618 PMID: 37922452
- 6. Cao L et al.. 2015. Negative Regulation of p21Waf1/Cip1 by Human INO80 Chromatin Remodeling Complex Is Implicated in Cell Cycle Phase G2/M Arrest and Abnormal Chromosome Stability.. PLoS One 10(9):e0137411 PMID: 26340092
- 7. Manzo SG et al.. 2024. Chromatin protein complexes involved in gene repression in lamina-associated domains.. EMBO J 43(21):5260-5287 PMID: 39322756
- 8. Volkman LE. 2015. Baculoviruses and nucleosome management.. Virology 476:257-263 PMID: 25569454
